Outlook Therapeutics
OTLK
#8491
Rank
S$0.17 B
Marketcap
$7.41
Share price
-7.55%
Change (1 day)
-38.00%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -S$0.13 Billion

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$69.29 Million, an increase over its 2022 earnings that were of -S$94.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.13 Billion82.52%
2023 -S$69.29 Million-26.7%
2022 -S$94.52 Million32.13%
2021 -S$71.54 Million46.21%
2020 -S$48.93 Million-18.82%
2019 -S$60.27 Million16.62%
2018 -S$51.68 Million57.88%
2017 -S$32.74 Million-56.17%
2016 -S$74.69 Million-9.26%
2015 -S$82.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.16 Billion 21.71% Jersey
-S$0.37 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$18.82 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$98.3 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK